Market Report, "Global Autoimmune Drugs Market 2016-2020", published

Autoimmune diseases are immunological disorders that occur when the immune system attacks and destroys healthy tissues in the body rather than foreign bodies, causing significant pain, inflammation, and organ damage. These diseases can affect the nervous system, cardiovascular system, and musculoskeletal system or individual organs, including the skin, lungs, kidneys, glands, and joints.
Autoimmune diseases occur due to genetic, infectious, or environmental factors. There are over 80 autoimmune diseases, including AS, IBD (CD and UC), MS, RA, SLE, and PsA. DMARDs, NSAIDs, corticosteroids, analgesics, and immunosuppressants are the major drug classes used to treat autoimmune diseases.

Full Report Details at
- http://www.fastmr.com/prod/1134195_global_autoimmune_drugs.aspx?afid=301

Technavio's analysts forecast the global autoimmune diseases drugs market to grow at a CAGR of 5.57% during the period 2016-2020.

Covered in this report
The report covers the present scenario and the growth prospects of the global autoimmune diseases drugs market for 2016-2020. To calculate the market size, the report considers revenue generated from the sales of branded, generic, and off-label drugs used for the treatment of autoimmune diseases.

The market is divided into the following segments based on geography:

* Americas
* APAC
* EMEA

Technavio's report, Global Autoimmune Diseases Drugs Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

* AbbVie Inc.
* Amgen Inc.
* Biogen
* F. Hoffmann-La Roche
* Johnson & Johnson Private Limited
* Pfizer Inc.

Other prominent vendors

* Ablynx
* AB Science
* Acorda Therapeutics
* Alder BioPharmaceuticals
* Antares Pharma
* Astellas Pharma
* AstraZeneca
* Baxter
* Boehringer Ingelheim
* Can-Fite BioPharma
* Celgene
* Celltrion
* ChemoCentryx
* Coherus BioSciences
* Daiichi Sankyo
* Eisai
* Eli Lilly
* Gilead Sciences
* GSK
* Hospira
* Idera Pharmaceuticals
* Immunomedics
* ImmuPharma
* Incyte
* Invion
* KaloBios Pharmaceuticals
* Lexicon Pharmaceuticals
* Merck
* MedImmune
* Morphotek
* Novo Nordisk
* Novartis
* Opexa Therapeutics
* Principia Biopharma
* Regeneron Pharmaceuticals
* Sandoz
* Sanofi
* Santarus
* Takeda Pharmaceuticals
* UCB
* Vaccinex
* Vertex Pharmaceuticals
* Vitae Pharmaceuticals

Market driver

* Promising pipeline
* For a full, detailed list, view our report

Market challenge

* Loss of patent exclusivity of branded therapies

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156 (1.413.485.7001 Int'l)

You may also be interested in these related reports:

- Autoimmune Hepatitis Global Clinical Trials Review, H1, 2015
- Acquired (Autoimmune) Hemolytic Anemia Global Clinical Trials Review, H2, 2015
- Global Systemic Lupus Erythematosus (SLE) Drugs Market 2015-2019
- Global Acne Drugs Market 2016-2020
- Global Hepatitis Drugs Market 2015-2019